+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Human Liver Model Market - Global Forecast 2026-2032- Product Image
Human Liver Model Market - Global Forecast 2026-2032- Product Image
New

Human Liver Model Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 185 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904934
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The human liver model market is evolving rapidly as advances in model engineering, new regulatory frameworks, and shifting research priorities drive adoption of higher-fidelity solutions across the life sciences. Senior decision-makers are seeking platforms that align with scientific rigor, operational needs, and translational objectives.

Market Snapshot: Human Liver Model Market Growth and Outlook

The human liver model market is poised for dynamic growth, expanding from USD 1.66 billion in 2025 to USD 1.78 billion in 2026, and projected to reach USD 3.05 billion by 2032 at a compound annual growth rate (CAGR) of 9.00%. This acceleration results from an increased demand for physiologically relevant in vitro models, fueled by shifting regulatory requirements and a sector-wide move to find alternatives to animal testing. Life sciences organizations are adapting investment and procurement strategies in response to innovations in three-dimensional cell culture, organoid systems, and integrated computational technologies. These factors are shaping the way suppliers are evaluated and selected across global research ecosystems.

Scope & Segmentation

  • Model Classes: Includes 2D monolayers, 3D cell cultures, ex vivo liver preparations, organoids, and in silico computational models, each varying in fidelity, scalability, and experimental control.
  • Cell Sourcing Strategies: Comprises immortalized cell lines, primary human hepatocytes, and stem cell-derived hepatocytes, offering options for throughput, donor specificity, and reproducibility.
  • Application Areas: The models are leveraged across drug discovery, toxicity screening, disease modeling, and academic training, with the choice guided by study requirements and throughput needs.
  • User Types: Key users encompass biopharma companies, contract research organizations, academic laboratories, and biotech firms, each with unique procurement practices and validation standards.
  • Geographic Coverage: Regional analysis encompasses the Americas, EMEA, and Asia-Pacific, factoring in the influence of regulatory standards, partnership approaches, and logistics.
  • Technologies Analyzed: Review includes three-dimensional culture platforms, organoid technologies, advanced imaging systems, single-cell analytics, and computational modeling in R&D processes.

Key Takeaways: Strategic Insights for Decision-Makers

  • Advancements in model engineering and bioinformatics empower organizations to achieve greater precision and scalability in preclinical research workflows.
  • Choices among models are shaped by priorities such as biological relevance, laboratory throughput, and required validation criteria, necessitating tailored adoption strategies.
  • Collaborative partnerships are evolving to emphasize ongoing, embedded validation within drug discovery and development pipelines.
  • Robust data stewardship and secure digital infrastructure now distinguish top suppliers, directly contributing to stronger positioning in competitive markets.
  • Navigating regional regulatory and operational complexities compels multinationals to refine approaches to product deployment and supplier relationships.

Tariff Impact: Adapting Supply Chains and Procurement Strategies

Recent adjustments to global tariff policies have prompted organizations to rethink and restructure their supply chains for laboratory consumables, equipment, and reagents. This environment has led leaders to diversify supplier bases, relocate manufacturing to favorable trade regions, and deepen collaboration with regional partners and contract research organizations. Strategies such as modular contracting, flexible supply agreements, and regional inventory management have become critical to minimizing cost exposures and maintaining business continuity in the face of trade-related uncertainty.

Methodology & Data Sources

This assessment is based on structured interviews with scientific and commercial stakeholders, supported by the analysis of peer-reviewed research, regulatory publications, and technical studies. The methodology ensures transparency, triangulating qualitative insights with reputable secondary sources and avoiding reliance on proprietary or undisclosed information.

Why This Report Matters

  • Clarifies how evolving human liver model segments and cell sourcing decisions directly impact R&D outcomes, procurement, and partnerships across the value chain.
  • Supports supplier selection and investment planning by mapping maturity and regulatory alignment of technologies across user groups and geographies.
  • Delivers actionable guidance to strengthen operational resilience and ensure compliance amid shifting procurement and regulatory environments.

Conclusion

The future of the human liver model market will be shaped by the integration of robust validation, operational resilience, and strategic collaboration. Senior leaders equipped with current intelligence will be best positioned to drive innovation and deliver impact in both scientific and business domains.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Human Liver Model Market, by Model Type
8.1. 2D Models
8.2. 3D Models
8.3. Ex Vivo Models
8.4. In Silico Models
8.5. Liver Organoids
9. Human Liver Model Market, by Cell Source
9.1. Immortalized Liver Cell Lines
9.2. Primary Human Hepatocytes
9.3. Stem Cell-Derived Models
10. Human Liver Model Market, by Application
10.1. Drug Discovery
10.2. Education
10.2.1. Physiological Studies
10.2.2. Toxicology Studies
11. Human Liver Model Market, by End Users
11.1. Biotech Companies
11.2. Contract Research Organizations
11.3. Pharmaceutical Companies
11.4. Research Laboratories
12. Human Liver Model Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Human Liver Model Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Human Liver Model Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Human Liver Model Market
16. China Human Liver Model Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Ascendance Bio
17.6. BioIVT LLC
17.7. Cellink Global by BICO Group AB
17.8. CN Bio Innovations Ltd.
17.9. Corning Incorporated
17.10. Cyfuse Biomedical K.K.
17.11. EISCO Scientific LLC
17.12. Emulate Inc.
17.13. Hurel Corporation
17.14. InSphero AG
17.15. Kirkstall Ltd
17.16. MIMETAS B.V.
17.17. NeurOmics, Inc.
17.18. Organovo Holdings Inc.
17.19. Pandorum Technologies Private Limited
17.20. PhoenixBio Co., Ltd.
17.21. STEMCELL Technologies Inc.
List of Figures
FIGURE 1. GLOBAL HUMAN LIVER MODEL MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL HUMAN LIVER MODEL MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL HUMAN LIVER MODEL MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES HUMAN LIVER MODEL MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA HUMAN LIVER MODEL MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL HUMAN LIVER MODEL MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY 2D MODELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY 2D MODELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY 2D MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY 3D MODELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY 3D MODELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY 3D MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY EX VIVO MODELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY EX VIVO MODELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY EX VIVO MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY IN SILICO MODELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY IN SILICO MODELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY IN SILICO MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY LIVER ORGANOIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY LIVER ORGANOIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY LIVER ORGANOIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY IMMORTALIZED LIVER CELL LINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY IMMORTALIZED LIVER CELL LINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY IMMORTALIZED LIVER CELL LINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY PRIMARY HUMAN HEPATOCYTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY PRIMARY HUMAN HEPATOCYTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY PRIMARY HUMAN HEPATOCYTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY STEM CELL-DERIVED MODELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY STEM CELL-DERIVED MODELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY STEM CELL-DERIVED MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY PHYSIOLOGICAL STUDIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY PHYSIOLOGICAL STUDIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY PHYSIOLOGICAL STUDIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY TOXICOLOGY STUDIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY TOXICOLOGY STUDIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY TOXICOLOGY STUDIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY BIOTECH COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY BIOTECH COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. AMERICAS HUMAN LIVER MODEL MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 57. AMERICAS HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 58. AMERICAS HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 59. AMERICAS HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 60. AMERICAS HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2032 (USD MILLION)
TABLE 61. AMERICAS HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 62. NORTH AMERICA HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. NORTH AMERICA HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 64. NORTH AMERICA HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 65. NORTH AMERICA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 66. NORTH AMERICA HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2032 (USD MILLION)
TABLE 67. NORTH AMERICA HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 68. LATIN AMERICA HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. LATIN AMERICA HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 70. LATIN AMERICA HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 71. LATIN AMERICA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 72. LATIN AMERICA HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2032 (USD MILLION)
TABLE 73. LATIN AMERICA HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA HUMAN LIVER MODEL MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2032 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 80. EUROPE HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. EUROPE HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 82. EUROPE HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 83. EUROPE HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 84. EUROPE HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2032 (USD MILLION)
TABLE 85. EUROPE HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 86. MIDDLE EAST HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. MIDDLE EAST HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 88. MIDDLE EAST HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 89. MIDDLE EAST HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 90. MIDDLE EAST HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2032 (USD MILLION)
TABLE 91. MIDDLE EAST HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 92. AFRICA HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. AFRICA HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 94. AFRICA HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 95. AFRICA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 96. AFRICA HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2032 (USD MILLION)
TABLE 97. AFRICA HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 98. ASIA-PACIFIC HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. ASIA-PACIFIC HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 100. ASIA-PACIFIC HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 101. ASIA-PACIFIC HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 102. ASIA-PACIFIC HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2032 (USD MILLION)
TABLE 103. ASIA-PACIFIC HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. ASEAN HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. ASEAN HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 107. ASEAN HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 108. ASEAN HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 109. ASEAN HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2032 (USD MILLION)
TABLE 110. ASEAN HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 111. GCC HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GCC HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 113. GCC HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 114. GCC HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 115. GCC HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2032 (USD MILLION)
TABLE 116. GCC HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 117. EUROPEAN UNION HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. EUROPEAN UNION HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 119. EUROPEAN UNION HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 120. EUROPEAN UNION HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 121. EUROPEAN UNION HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2032 (USD MILLION)
TABLE 122. EUROPEAN UNION HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 123. BRICS HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. BRICS HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 125. BRICS HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 126. BRICS HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 127. BRICS HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2032 (USD MILLION)
TABLE 128. BRICS HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 129. G7 HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. G7 HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 131. G7 HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 132. G7 HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 133. G7 HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2032 (USD MILLION)
TABLE 134. G7 HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 135. NATO HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. NATO HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 137. NATO HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 138. NATO HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 139. NATO HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2032 (USD MILLION)
TABLE 140. NATO HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. UNITED STATES HUMAN LIVER MODEL MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 143. UNITED STATES HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 144. UNITED STATES HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 145. UNITED STATES HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 146. UNITED STATES HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2032 (USD MILLION)
TABLE 147. UNITED STATES HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 148. CHINA HUMAN LIVER MODEL MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 149. CHINA HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 150. CHINA HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 151. CHINA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 152. CHINA HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2032 (USD MILLION)
TABLE 153. CHINA HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Human Liver Model market report include:
  • Ascendance Bio
  • BioIVT LLC
  • Cellink Global by BICO Group AB
  • CN Bio Innovations Ltd.
  • Corning Incorporated
  • Cyfuse Biomedical K.K.
  • EISCO Scientific LLC
  • Emulate Inc.
  • Hurel Corporation
  • InSphero AG
  • Kirkstall Ltd
  • MIMETAS B.V.
  • NeurOmics, Inc.
  • Organovo Holdings Inc.
  • Pandorum Technologies Private Limited
  • PhoenixBio Co., Ltd.
  • STEMCELL Technologies Inc.

Table Information

Report AttributeDetails
No. of Pages185
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.78 Billion
Forecasted Market Value ( USD ) by 2032 $ 3.05 Billion
Compound Annual Growth Rate9.0%
Regions CoveredGlobal
No. of Companies Mentioned18

Related Topics

Related Reports

Human Liver Model Market: Analysis by Product Type, Application, End-use, and Region - Size, Trends and Forecasts to 2030 - Product Image

Human Liver Model Market: Analysis by Product Type, Application, End-use, and Region - Size, Trends and Forecasts to 2030

  • Report
  • 148 Pages
  • Global
From
Human Liver Model Market Report 2025 - Product Image

Human Liver Model Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Human Liver Models - Global Strategic Business Report - Product Image

Human Liver Models - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Humanized Mouse and Rat Model Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Image

Humanized Mouse and Rat Model Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Organs-on-chips Market - Global Forecast 2026-2032 - Product Image

Organs-on-chips Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From

About the Human Liver Model Market

The Human Liver Model market is a subset of the Clinical Trials market, focused on the development of in vitro models of the human liver. These models are used to study the effects of drugs and other compounds on the liver, and to predict the safety and efficacy of drugs in humans. The models are typically composed of human liver cells, and can be used to study the metabolism, toxicity, and pharmacokinetics of drugs. The models are also used to study the effects of genetic and environmental factors on the liver. The Human Liver Model market is growing due to the increasing demand for in vitro models for drug development and safety testing. The models are also being used to study the effects of diseases on the liver, such as hepatitis and cirrhosis. Companies in the Human Liver Model market include InSphero, Hepregen, and Emulate. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.